What do systematic reviews say?

Pericyazine vs Typical antipsychotics

It is very uncertain whether pericyazine changes global state ‐ not improved compared with typical antipsychotic (very low certainty).

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  RR 1.24 [0.93, 1.66]
  2 studies · 122 participants
  Very low

Pericyazine vs atypical antipsychotics

The review found no eligible studies for this question.

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pericyazine vs atypical antipsychotics

It is very uncertain whether pericyazine changes leaving the study early for specific reasons compared with atypical antipsychotic (very low certainty).

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  RR 0.46 [0.11, 1.9]
  1 study · 93 participants
  Very low

Pericyazine vs atypical antipsychotics

The review found no eligible studies for this question.

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pericyazine vs atypical antipsychotics

The review found no eligible studies for this question.

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pericyazine vs Typical antipsychotics

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Very low

Pericyazine vs Typical antipsychotics

It is very uncertain whether pericyazine changes adverse events ‐ for specific reasons ‐ Extrapyramidal side effect compared with typical antipsychotic (very low certainty).

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  RR 0.59 [0.38, 0.89]
  3 studies · 163 participants
  Very low

Pericyazine vs Typical antipsychotics

The review found no eligible studies for this question.

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pericyazine vs Typical antipsychotics

It is very uncertain whether pericyazine changes leaving the study early for specific reasons compared with typical antipsychotic (very low certainty).

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  RR 0.46 [0.11, 1.9]
  2 studies · 71 participants
  Very low

Pericyazine vs Typical antipsychotics

The review found no eligible studies for this question.

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pericyazine vs Typical antipsychotics

The review found no eligible studies for this question.

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pericyazine vs atypical antipsychotics

It is very uncertain whether pericyazine changes global state ‐ not improved compared with atypical antipsychotic (very low certainty).

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  RR 0.97 [0.67, 1.42]
  1 study · 93 participants
  Very low

Pericyazine vs atypical antipsychotics

It is very uncertain whether pericyazine changes adverse Effects ‐ Extrapyramidal symptoms compared with atypical antipsychotic (very low certainty).

• Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
  RR 2.69 [1.35, 5.36]
  1 study · 93 participants
  Very low